4TISSUE
LIVE

Serial Number

79448423

Owner

4Tissue BV

Attorney

Clifford D. Hyra

Filing Date

Dec 18, 2025

Add to watchlist:

No watchlists yet
View on USPTO

4TISSUE Trademark

Serial Number: 79448423

4TISSUE is a trademark filed by 4Tissue BV on December 18, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

4Tissue BV (2 trademarks)

Technologiepark-Zwijnaarde 48

Entity Type: 26

Trademark Details

Filing Date

December 18, 2025

Registration Date

Not Registered

Goods & Services

Research, design and development services in the field of biomaterials, regenerative medicine and drug delivery systems; Medical research in the field of regenerative medicine and drug delivery systems; Conducting scientific studies in the field of biomaterials, regenerative medicine and drug delivery systems; Testing and inspection services in the field of biomaterials, regenerative medicine and drug delivery systems, being the inspection of medical, medicinal, pharmaceutical or combinational products for quality control purposes; Scientific laboratory services; Scientific and medical research and development relating to products, technologies and treatments in the field of regenerative medicine and drug delivery systems for market approval through clinical validation and conducting clinical trials related thereto; Culturing cells and tissues for others for scientific research purposes; Synthesis of biomaterials for scientific research services

Medical preparations aimed at restoring the function of cells, tissues and organs, being medical preparations for the treatment of soft tissue defects and wound healing; Medical products, namely, implantable natural scaffolds mimicking the extracellular matrix aimed at functional restoration of cells, tissues and organs; Medical preparations and products that serve as carriers for drugs, cells and cell derivatives, such as stem cells for medical purposes

Medical services in the field of regenerative medicine and drug delivery systems; Medical treatments, being medical services involving the treatment of soft tissue defects using injections, implants, and the oral, topical and external administration, in the field of regenerative medicine and drug delivery systems; Medical laboratory analysis services relating to the analysis of medic(in)al products; Medical advice in the field of regenerative medicine and drug delivery systems; Providing medical information in the field of regenerative medicine and drug delivery systems

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 3, 2026 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 27, 2026 NREP
REFUSAL PROCESSED BY IB
Jul 16, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 27, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jun 27, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 2, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 1, 2026 CNRT
ASSIGNED TO EXAMINER
Apr 28, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 27, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2026 REPR